|
Volumn 43, Issue 4, 2011, Pages 1244-1246
|
H1N1 vaccination in pediatric renal transplant patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALUMINUM PHOSPHATE;
CALCINEURIN INHIBITOR;
FLUVAL P;
IMMUNOLOGICAL ADJUVANT;
INFLUENZA VACCINE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
UNCLASSIFIED DRUG;
ABSENCE OF SIDE EFFECTS;
ADOLESCENT;
ADOLESCENT DISEASE;
ADULT;
ANTIBODY PRODUCTION;
ANTIBODY RESPONSE;
ANTIBODY TITER;
CHILD;
CHILDHOOD DISEASE;
CLINICAL ARTICLE;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
GRAFT RECIPIENT;
GROUPS BY AGE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION PREVENTION;
INFLUENZA A (H1N1);
INFLUENZA VIRUS A H1N1;
KIDNEY GRAFT;
KIDNEY GRAFT REJECTION;
MALE;
NONHUMAN;
PANDEMIC INFLUENZA;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
SCHOOL CHILD;
SEROCONVERSION;
SINGLE DRUG DOSE;
VACCINATION;
ADOLESCENT;
ANTIBODIES, VIRAL;
CHI-SQUARE DISTRIBUTION;
CHILD;
FEMALE;
HUMANS;
HUNGARY;
IMMUNIZATION, SECONDARY;
IMMUNOSUPPRESSIVE AGENTS;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
KIDNEY TRANSPLANTATION;
MALE;
RISK ASSESSMENT;
RISK FACTORS;
TIME FACTORS;
TREATMENT OUTCOME;
YOUNG ADULT;
|
EID: 79957611445
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2011.03.072 Document Type: Conference Paper |
Times cited : (13)
|
References (6)
|